Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
25,315
Total Claims
$1.3M
Drug Cost
402
Beneficiaries
$3,186
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+126%
Cost per patient vs peers
$3,186 vs $1,411 avg
-35%
Brand preference vs peers
6.9% vs 10.6% avg
Brand vs Generic
Brand: 1,752 claims · $773K
Generic: 23,476 claims · $501K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Valbenazine Tosylate | 13 | $111K |
| Adalimumab | 12 | $88K |
| Apixaban | 152 | $64K |
| Paliperidone Palmitate | 17 | $61K |
| Elviteg/Cob/Emtri/Tenof Alafen | 12 | $48K |
| Sitagliptin Phosphate | 79 | $47K |
| Chlorpromazine Hcl | 401 | $46K |
| Empagliflozin | 112 | $30K |
| Iloperidone | 46 | $29K |
| Divalproex Sodium | 1,010 | $29K |
| Potassium Chloride | 327 | $25K |
| Linaclotide | 38 | $21K |
| Insulin Detemir | 17 | $21K |
| Dextromethorphan Hbr/Quinidine | 44 | $19K |
| Aripiprazole | 107 | $16K |
Prescribing Profile
Patient Profile
69
Avg Age
46%
Female
1.50
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data